Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. Fernández-Ramos, A. A., Poindessous, V., Marchetti-Laurent, C., Pallet, N. & Loriot, M.-A. The effect of immunosuppressive molecules on T-cell metabolic reprogramming. Biochimie 127, 23–36 (2016).
2. Phan, L., Yeung, S. & Lee, M. Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies. Cancer Biol Med 11, 1–19 (2014).
3. Quéméneur, L. et al. Differential control of cell cycle, proliferation, and survival of primary T lymphocytes by purine and pyrimidine nucleotides. J Immunol 170, 4986–4995 (2003).
4. Jiang, P., Du, W. & Du, M. Regulation of the pentose phosphate pathway in cancer. Protein Cell 5, 592–602 (2014).
5. Herbel, C. et al. Clinical significance of T cell metabolic reprogramming in cancer. Clin Transl Med 5, 1–23 (2016).
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献